NEW YORK (360Dx) – A new collaboration was announced today aimed at shedding light on differences in type 2 diabetes.

Roche Diagnostics, Eli Lilly, the Indiana Biosciences Research Institute, the Regenstrief Institute, and Indiana University School of Medicine are collaborating to better understand how T2D varies among patients, with the goal of developing improved diagnostic tools and new treatments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.